Skip to main content
main-content

04-08-2017 | Gout | Article

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

Please follow the link below to view this article in full on a third party website. Note that a subscription or payment may be required.

Please log in to get access to this content

Related topics